Skip to main content
. Author manuscript; available in PMC: 2019 Oct 17.
Published in final edited form as: Sci Transl Med. 2019 Apr 17;11(488):eaav0936. doi: 10.1126/scitranslmed.aav0936

Figure 1. PDX models of treatment-naïve TNBC exhibit diverse responses to AC.

Figure 1.

One or two cycles of AC were administered to PDX models of treatment-naïve TNBC starting on day zero (arrows). All PDXs were derived from primary tumors with the exception of PIM001-M, which was derived from the dermal metastasis to the chest wall of the same patient from whom PIM001-P (primary tumor) was derived. Data shown are mean +/− standard error of the mean (SEM; n=3 per group).